Rodotium, 450 mg/g suukaudse lahuse graanulid sigadele
Rodotium, 450 mg/g suukaudse lahuse graanulid sigadele
Authorised
- Tiamulin hydrogen fumarate
Product identification
Medicine name:
Rodotium, 450 mg/g suukaudse lahuse graanulid sigadele
Active substance:
- Tiamulin hydrogen fumarate
Target species:
-
Pig
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Tiamulin hydrogen fumarate450.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Granules for oral solution
Withdrawal period by route of administration:
-
Oral use
-
Pig
-
Meat and offal5day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XQ01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Huvepharma EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1611
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 9/07/2025